KRTX
Karuna Therapeutics, Inc.
191.49
USD
This page is just a preview of the data found in TrendSpider’s full version
Karuna Therapeutics, Inc. stock is up 18.28% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 4 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 31 Oct 15:17 | 17 Nov, 2023 | 190.00 | 304 | ||
| 31 Oct 16:54 | 17 Nov, 2023 | 180.00 | 29 | ||
| 03 Nov 17:36 | 19 Jan, 2024 | 170.00 | 81 | ||
| 10 Nov 17:56 | 19 Jan, 2024 | 185.00 | 7 | ||
| 17 Nov 19:39 | 17 May, 2024 | 240.00 | 2 | ||
| 17 Nov 19:40 | 17 May, 2024 | 240.00 | 2 | ||
| 22 Nov 19:34 | 19 Jan, 2024 | 175.00 | 954 | ||
| 24 Nov 14:53 | 19 Jan, 2024 | 165.00 | 34 | ||
| 24 Nov 16:16 | 19 Jan, 2024 | 180.00 | 33 | ||
| 24 Nov 17:48 | 19 Jan, 2024 | 170.00 | 19 |
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia.
